bioRxivCancer BiologyPreprint
The PAXFOXO1s trigger fast trans-differentiation of chick embryonic neural cells into alveolar rhabdomyosarcoma with tissue invasive properties limited by S phase entry inhibition
G. GONZALEZ CURTO, A. Der Vartanian, Y. FRARMA, L. Manceau, L. Baldi, S. Prisco, N. ELAROUCI, F. Causeret, M. RIGOLET, F. AURADE, A. DE REYNIES, V. CONTREMOULINS, F. RELAIX, O. FAKLARIS, J. BRISCOE, P. GILARDI-HEBENSTREIT, V. RIBES
Abstract
The chromosome translocations generating PAX3FOXO1 and PAX7FOXO1 chimeric proteins are the primary hallmarks of the paediatric cancer, Alveolar Rhabdomyosarcoma (ARMS). Despite the ability of these transcription factors to remodel chromatin landscapes and promote the expression of tumour driver genes, they only inefficiently promote malignant transformation in vivo. The reason for this is unclear. To address this, we developed an in ovo model to follow the response of spinal cord progenitors to PAXFOXO1s. Our data demonstrate that PAXFOXO1s, but not wild-type PAX3 and PAX7, trigger the trans-differentiation of neural cells into ARMS-like cells with myogenic characteristics. In parallel expression of PAXFOXO1s remodels the neural pseudo-stratified epithelium into a cohesive mesenchyme capable of tissue invasion. Surprisingly, gain for PAXFOXO1s, as for wild-type PAX3/7, reduces the levels of CDK-CYCLIN activity and arrests cells in G1. Introduction of CYCLIN D1 or MYCN overcomes PAXFOXO1s mediated cell cycle inhibition and promotes tumour growth. Together, our findings reveal a mechanism underpinning the apparent limited oncogenicity of PAXFOXO1 fusion transcription factors and support a neural origin for ARMS.
- organism: chicken / avian
- research focus: cancer & tumor microenvironment
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Myogenic and neural transcriptional circuitry determines PAX3::FOXO1 driven initiation of rhabdomyosarcoma
Bradley T. Stevens, Yang Zhang, … Mark E. Hatley·bioRxiv·Oct 29, 2026
- Divergent transcriptional and transforming properties of PAX3-FOXO1 and PAX7-FOXO1 paralogs
L. MANCEAU, J. RICHARD ALBERT, … V. Ribes·bioRxiv·Aug 18, 2021
- Rhabdomyosarcoma fusion oncoprotein initially pioneers a neural signature in vivo
Jack P. Kucinski, Alexi M Tallan, … Genevieve C. Kendall·Cell ReportsPeer-reviewed·Jul 1, 2025
- PAX fusion proteins deregulate gene networks controlling mitochondrial translation in pediatric rhabdomyosarcoma
Bhargab Kalita, Gerard Martínez-Cebrián, … Brian David Dynlacht·CellPeer-reviewed·Aug 3, 2024
- Fusion transcription factor dosage controls cell state in rhabdomyosarcoma
Rachel A. Hoffman, Meng Wang, … Benjamin Z. Stanton·bioRxiv·May 16, 2025
- Comparative modes of chromatin engagement by PAX::FOXO1 fusions in rhabdomyosarcoma
Alexi M Tallan, Jack P. Kucinski, … Benjamin Z. Stanton·bioRxiv·Feb 19, 2026